Home Cart Sign in  
Chemical Structure| 110044-82-1 Chemical Structure| 110044-82-1

Structure of MG-101
CAS No.: 110044-82-1

Chemical Structure| 110044-82-1

MG-101

CAS No.: 110044-82-1

MG-101 is a potent inhibitor of cysteine proteases including calpain I (Ki = 190 nM), calpain II (Ki = 220 nM), cathepsin B (Ki = 150 nM), and cathepsin L (Ki = 500 pM).

Synonyms: Calpain inhibitor I; ALLN; AcLLnLCHO, Ac-Leu-Leu-Nle-Aldehyde.

4.5 *For Research Use Only !

Cat. No.: A158847 Purity: 98+%

Change View

Size Price

US Stock

Global Stock

In Stock
25mg łÇËď¶ÊÊ Inquiry Inquiry
50mg łËÊʶÊÊ Inquiry Inquiry
100mg ł§Çď¶ÊÊ Inquiry Inquiry
250mg łÍòď¶ÊÊ Inquiry Inquiry
1g łÇÇî§¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • 25mg

    łÇËď¶ÊÊ

  • 50mg

    łËÊʶÊÊ

  • 100mg

    ł§Çď¶ÊÊ

  • 250mg

    łÍòď¶ÊÊ

  • 1g

    łÇÇî§¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of MG-101

CAS No. :110044-82-1
Formula : C20H37N3O4
M.W : 383.53
SMILES Code : O=C(N[C@H](C=O)CCCC)[C@@H](NC([C@@H](NC(C)=O)CC(C)C)=O)CC(C)C
Synonyms :
Calpain inhibitor I; ALLN; AcLLnLCHO, Ac-Leu-Leu-Nle-Aldehyde.
MDL No. :MFCD00065505
InChI Key :FMYKJLXRRQTBOR-BZSNNMDCSA-N
Pubchem ID :443118

Safety of MG-101

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P271-P280

Related Pathways of MG-101

pyroptosis

Isoform Comparison

Biological Activity

Target
  • Cysteine Protease

In Vitro:

Cell Line
Concentration Treated Time Description References
Huh7 cells 80 nM, 0.8 µM, 4 µM, 20 µM, 100 µM 1 hour To evaluate the inhibitory effect of MG-101 on SARS-CoV-2 pseudovirus infection, the results showed that MG-101 significantly inhibited pseudovirus infection with an EC50 value of 3.12 μM. PMC9110316
A549 cells 80 nM, 0.8 µM, 4 µM, 20 µM, 100 µM 1 hour To evaluate the inhibitory effect of MG-101 on SARS-CoV-2 pseudovirus infection, the results showed that MG-101 significantly inhibited pseudovirus infection with an EC50 value of 1.15 μM. PMC9110316
MiaPaCa-2 cells 5 µM 20 hours To evaluate whether MG-101 mediates proteasomal or lysosomal degradation of Bcl-2, results showed that MG-101 failed to prevent the downregulation of Bcl-2 by PM. PMC4027926
Panc-1 cells 5 µM 20 hours To evaluate whether MG-101 mediates proteasomal or lysosomal degradation of Bcl-2, results showed that MG-101 failed to prevent the downregulation of Bcl-2 by PM. PMC4027926
Huh-7.5 cells 0.038 µM 24 hours MG-101 inhibits SARS-CoV-2 replication with an EC50 of 0.038 μM PMC8881501
HEK293T cells 10 µM 24 hours MG-101 inhibits Mpro activity, reducing protease activity by 50% PMC8881501

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.04mL

2.61mL

1.30mL

26.07mL

5.21mL

2.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories